Dr. Sarah Harris Cash, MD

Dr. Cash practices at Wnc Dermatological Associates PA in Asheville, North Carolina.

Dr. Cash's NPI, 1245216514, was assigned on December 19, 2005. Dr. Cash graduated from West Virginia University School Of Medicine in 2000. Dr. Cash holds North Carolina license 200101434.

Dr. Cash's primary practice is Wnc Dermatological Associates PA, at 281 McDowell St, Asheville, NC 28803 in Buncombe County. The practice phone is (828) 252-5676.

Dr. Cash's primary practice is Wnc Dermatological Associates PA in Asheville, North Carolina. Dr. Cash is also affiliated with Mission Hospital. The medical group on file is WNC Dermatology. Dmand AI also links Dr. Cash to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Cash practices, 2 sites in all. Vendor and product names are available with a free account.

Dermatology is Dr. Cash's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Cash is board certified in dermatology by the American Board of Dermatology. Dmand AI has Dr. Cash's licenses on file in 2 states: North Carolina and Pennsylvania.

Dmand AI lists acne, acute skin infection, benign or precancerous skin growths, cancerous skin growth removal, cold sores or genital herpes, contact dermatitis, facial skin infection and hives among the conditions Dr. Cash treats.

CMS data shows 3,114 Medicare services from Dr. Cash across 14 procedure codes in 2024, for 760 Medicare patients. Medicare paid $136,875 for them. Every service was in an office.

CMS counts 760 Medicare patients who saw Dr. Cash in 2024. The largest group is 65 to 74, with 413 patients. 67% of them have high cholesterol, and 60% have high blood pressure. 2% are also on Medicaid. Their average risk score is 0.82, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Cash's median patient age at 75, with 65% women.

In 2024, Dr. Cash wrote 1,081 Medicare Part D claims for 382 patients. 88% of them were for generic drugs. CMS names the drug for 925 of them, across 23 drugs with 11 or more claims each, at $496,143 in total drug cost. In 2023, CMS named 802 claims across 22 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 98 out of 100 for Dr. Cash for performance year 2024, reported as part of a group. Dr. Cash accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 875 procedures of removal of skin lesions by Dr. Cash, more than 92% of the clinicians it reports for that procedure.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 4 papers to Dr. Cash. The most frequent topics are Epidermolysis Bullosa.

CMS Open Payments shows 549 general payments to Dr. Cash from 35 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 71% of the total. Abbvie Inc. paid the most, $168,802.

Dmand AI lists 1 award for Dr. Cash.

Dr. Cash graduated from West Virginia University School Of Medicine in 2000. Dr. Cash is a member of AAD.

Dr. Cash is in network with 18 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.